These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells.
    Author: Kavallaris M, Gardaneh M, Cheung B, Camacho ML, Hocker JE, Norris MD, Haber M, Marshall GM.
    Journal: Anticancer Res; 1998; 18(3A):1793-7. PubMed ID: 9673406.
    Abstract:
    Amplification of the MYCN oncogene is a strong predictor of treatment failure and chemo-resistance in childhood neuroblastoma. Stable expression of two partial MYCN gene fragments in antisense orientation reduced Mycn protein expression in an MYCN-amplified neuroblastoma tumor cell line, however, antisense cells did not exhibit an increased in vitro sensitivity to cytotoxic or differentiating agents. In contrast, partial MYCN sense transfectants exhibited increased resistance to cytotoxic drugs. These data suggest that the chemo-resistance of MYCN-amplified neuroblastoma cells is complex, and may be due to factors additional to Mycn protein expression.
    [Abstract] [Full Text] [Related] [New Search]